Harmony Biosciences
Commercializes WAKIX for narcolepsy while developing next-generation pitolisant and rare-neurology therapies.
$39.21
After-hours close−0.01 (−0.03%)
At close$39.22(−1.63%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 97.78%56.61M sharesInsiders 0.11%64.3K sharesOther 2.11%1.22M shares
Shares outstanding 57.89M · Float 50.37M · 87.0% free float
Institutions13F, as of Jun 30, 2026
335 holders · 56.61M shares · 52 new positions · 185 increased · 107 reduced · 37 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.10M | 12.27% | +31.9K | Aug 7, 2026 |
| FMR LLC | 3.57M | 6.17% | +416.5K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 2.88M | 4.98% | +166.1K | Aug 13, 2026 |
| American Century Companies Inc | 2.54M | 4.39% | +434.3K | Aug 12, 2026 |
| Dimensional Fund Advisors LP | 2.39M | 4.13% | +317.1K | Aug 11, 2026 |
| Vanguard Capital Management LLC | 2.11M | 3.64% | +2.7K | Aug 13, 2026 |
| LSV Asset Management | 2.06M | 3.56% | +36.1K | Aug 6, 2026 |
| State Street Corp | 1.86M | 3.21% | +75.0K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Marshman Fund Trust II | 10.60% | 6.05M | 13G | Feb 10, 2025 ↗ |
| BlackRock, Inc. | 10.10% | 5.77M | 13G | Apr 29, 2025 ↗ |
| FMR LLC | 5.40% | 3.11M | 13G | Feb 5, 2026 ↗ |
| Vanguard Portfolio Management | 5.08% | 2.94M | 13G | Jul 31, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Sandip Kapadia | officer: CHIEF FINANCIAL OFFICER | 24.5K | 0.04% | Jan 28, 2026 |
| Kumar Budur | officer: CHIEF MEDICAL OFFICER | 24.1K | 0.04% | May 18, 2026 |
| Jeffrey M. Dayno | director, officer: PRESIDENT, CEO | 7.3K | 0.01% | Jan 26, 2026 |
| Adam H. Zaeske | officer: CHIEF COMMERCIAL OFFICER | 4.3K | 0.01% | Apr 9, 2026 |
| Stephen M. Mollichella | officer: INT PRINCIAL FINANCIAL OFFICER | 2.5K | 0.00% | Jul 22, 2026 |
| Andrew Serafin | officer: CHIEF STRATEGY OFFICER | 1.5K | 0.00% | Jan 26, 2026 |
2 ten-percent owners hold 9.81M shares by Form 4, outside the officers-and-directors figure above · 3 people have not refiled in the last 18 months (4.97M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jan 26, 2026 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 3,746 | $37.15 | 24,521 |
| Jan 15, 2026 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 20,961 | $35.92 | 0 |
| Dec 12, 2025 | Jeffrey M. Daynodirector, officer: PRESIDENT, CEO | Sale | 5,933 | $40.11 | 0 |
| Dec 5, 2025 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 20,000 | $39.54 | 0 |
| Nov 21, 2025 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 3,427 | $35.00 | 0 |
CongressHouse and Senate disclosures
Not reported.